Advertisement

Ads Placeholder
Loading...

Carmell Therapeutics Corporation

CTCXW•NASDAQ
Healthcare
Biotechnology
$0.03
$-0.02(-45.40%)
U.S. Market opens in 52h 24m

Carmell Therapeutics Corporation (CTCXW) Stock Overview

Explore Carmell Therapeutics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap558.2K
P/E Ratio-0.08
EPS (TTM)N/A
ROE1.41%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CTCXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Carmell Therapeutics Corporation (CTCXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.08 and a market capitalization of 558.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-51.45%
6-Month Change
-73.30%
Year-to-Date (YTD) Change
-44.95%
1-Year Change
-82.19%
3-Year Change
-93.49%
5-Year Change
-93.49%
All-Time (Max) Change
-93.49%

Contact Information

https://www.carmellrx.com
412 894 8248
2403 Sidney Street, Pittsburgh, PA, 15203

Company Facts

90 Employees
CountryUS

Frequently Asked Questions